Render Target: STATIC
Render Timestamp: 2024-11-29T10:42:36.006Z
Commit: cd2fae6ca3f811b1ddb1df24ac291ed56d5d501b
XML generation date: 2024-09-30 01:58:39.019
Product last modified at: 2024-09-30T08:01:56.034Z
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

RHBDF2 (E7U2K) Rabbit mAb #26182

Filter:
  • WB

    Supporting Data

    REACTIVITY H
    SENSITIVITY Endogenous
    MW (kDa) 97
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    Species Cross-Reactivity Key:
    • H-Human 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    RHBDF2 (E7U2K) Rabbit mAb recognizes endogenous levels of total RHBDF2 protein. Bands of unknown identity are detected at 50 kDa and 160 kDa.

    Species Reactivity:

    Human

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Lys36 of human RHBDF2 protein.

    Background

    Inactive rhomboid factor 2 (RHBDF2), also known as RHBDL6 or iRhom2, is a proteolytically inactive member of the transmembrane family of rhomboid serine protease family (1). Inactive rhomboid family members have been implicated in several physiological and pathophysiological conditions, including wound healing, cancer, neurodegenerative diseases, and inflammatory disorders (reviewed in 2). RHBDF2 facilitates endoplasmic reticulum trafficking of the metalloprotease ADAM17 (also known as TACE) to the membrane, thereby promoting EGF family growth factor and cytokine shedding and signaling (1). Loss of RHBDF2 results in significantly reduced secretion of ligand-mediated secretion of these factors. Inherited dominant mutations in the RHBDF2 gene are the genetic basis for the cancer-susceptibility syndrome tylosis with esophageal cancer (TOC) (3). Elevated expression of RHBDF2 in oral squamous carcinoma is associated with tumor progression and poor patient prognosis (4). The E3 ubiquitin ligase TRIM31 directly targets RHBDF2 and facilitates its proteasomal degradation (5). Hepatocyte specific ablation of TRIM31 facilitates phenotypes of non-alcoholic fatty liver disease (5).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.